VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2020 | Updates from the MEDALIST study

Amer Zeidan, MBBS, MHS, of Yale University and Yale Cancer Center, New Haven, CT, outlines results from the Phase III MEDALIST study (NCT02631070), investigating the clinical benefit of luspatercept in patients with lower-risk myelodysplastic syndrome and high transfusion burden. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter